Millennium Pharmacon International Tbk. vs Zyrexindo Mandiri Buana Tbk. — how do they compare? Millennium Pharmacon International Tbk. trades at Rp179 (market cap 230.59B, 19.2K 24h volume), while Zyrexindo Mandiri Buana Tbk. trades at Rp129 (market cap 173.33B, 1.04M 24h volume). The key difference: Millennium Pharmacon International Tbk. is the larger of the two by market cap, and Zyrexindo Mandiri Buana Tbk. is more actively traded (1.04M versus 19.2K). Which is the better fit depends on your goals.
| SDPC | ZYRX | |
|---|---|---|
Market Cap | 230.59B | 173.33B |
Volume | 19.2K | 1.04M |
Lot | 192 | 10.41K |
Turnover | 3.43M | 134.49M |
Average Price | 178.62 | 129.19 |
Value | 3.43M | 134.49M |
Indicative Equilibrium Price | — | 129 |
Indicative Equilibrium Volume | — | 15 |
Trailing returns across standard periods
Latest headlines on both assets
PT Millennium Pharmacon International Tbk (the Company) was established on October 20th, 1952 under the name N.V. Perusahaan Dagang SOEDARPO CORPORATION. On July 29th, 1997, the Extraordinary Shareholders meeting held by the Company has approved the sale of assets and of the whole share participation on the Company in PT Praweda Ciptakarsa Informatika and PT Sumber Daya Praweda Informatika. In order to strengthen its equity and settle the foreign currently loan, the Company has conducted its first Right Issue and has submitted the registration statement on May 8th, 2000 to the Capital Advisory Board (BAPEPAM). The Company started its operations on October 20, 1952. The name was changed from previous name PT NVPD Soedarpo Corporation.
Read more on SDPC →PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik
Read more on ZYRX →